Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Hoth Therapeutics Inc.

    NASDAQ: HOTH · Real-Time Price · USD
    1.31
    -0.11 (-7.75%)
    At close: Jun 13, 2025, 3:59 PM
    1.28
    -2.29%
    After-hours: Jun 13, 2025, 07:58 PM EDT

    Hoth Therapeutics Statistics

    Share Statistics

    Hoth Therapeutics has 13.21M shares outstanding. The number of shares has increased by 145.35% in one year.

    Shares Outstanding

    n/a
    		 13.21M

    Shares Change (YoY)

    n/a
    		 145.35%

    Shares Change (QoQ)

    n/a
    		 90.44%

    Owned by Institutions (%)

    n/a
    		 3.34%

    Shares Floating

    n/a
    		 13.14M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,880

    FTD / Avg. Volume

    n/a
    		 0.17%

    Short Selling Information

    The latest short interest is 56.21K, so 0.43% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 56.21K

    Short % of Shares Out

    n/a
    		 0.43%

    Short % of Float

    n/a
    		 0.43%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.58 and the forward PE ratio is -3.29. Hoth Therapeutics's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.58

    Forward PE

    n/a
    		 -3.29

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.69

    P/FCF Ratio

    n/a
    		 -0.68

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Hoth Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.2, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 9.2

    Quick Ratio

    n/a
    		 9.2

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-4,094,150

    Employee Count

    n/a
    		 2

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 36.46% in the last 52 weeks. The beta is 0.55, so Hoth Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.55

    52-Week Price Change

    n/a
    		 36.46%

    50-Day Moving Average

    n/a
    		 0.93

    200-Day Moving Average

    n/a
    		 0.98

    Relative Strength Index (RSI)

    n/a
    		 59.93

    Average Volume (20 Days)

    n/a
    		 1,122,261

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -8.22M

    Net Income

    n/a
    		 -8.19M

    EBITDA

    n/a
    		 -8.19M

    EBIT

    n/a
    		 -8.19M

    Earnings Per Share (EPS)

    n/a
    		 -1.28
    Full Income Statement

    Balance Sheet

    The company has 7.04M in cash and 31.07K in debt, giving a net cash position of 7.01M.

    Cash & Cash Equivalents

    n/a
    		 7.04M

    Total Debt

    n/a
    		 31.07K

    Net Cash

    n/a
    		 7.01M

    Retained Earnings

    n/a
    		 -60.41M

    Total Assets

    n/a
    		 12.36M

    Working Capital

    n/a
    		 11.48M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -6.98M and capital expenditures 0, giving a free cash flow of -6.98M.

    Operating Cash Flow

    n/a
    		 -6.98M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -6.98M

    FCF Per Share

    n/a
    		 -1.09
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    HOTH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for HOTH is $4.5, which is 243.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $4.5

    Price Target Difference

    n/a
    		 243.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 26, 2022. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Oct 26, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -0.46

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist